» Articles » PMID: 33061763

A Case of Classic Galactosemia Manifesting As Neonatal Early and Profound Indirect Hyperbilirubinemia

Overview
Publisher Kare Publishing
Specialty Pediatrics
Date 2020 Oct 16
PMID 33061763
Citations 1
Authors
Affiliations
Soon will be listed here.
Abstract

Galactosemia is a rare autosomal recessive metabolic disorder that has three major types. The most common type is classic galactosemia. These patients have deficient galactose-1-phosphate-urydiltransferase. The enzyme deficiency often results in symptomatic disease if breastfeeding or lactose-containing formulas continue. Neonatal jaundice is among the most prevalent symptoms. Although patients with classic galactosemia mostly demonstrate direct neonatal hyperbilirubinemia (cholestasis), seldom they may initially have indirect hyperbilirubinemia. Herein, we present a newborn with initial neonatal profound indirect hyperbilirubinemia who responded well to intensive phototherapy, then presented with cholestasis and was finally diagnosed as having classic galactosemia. Unfortunately, major textbooks of neonatology and pediatrics are still missing galactosemia as one of the differential diagnoses of neonatal indirect hyperbilirubinemia. It is just mentioned as prolonged or direct neonatal hyperbilirubinemia. We recommend that galactosemia be included in the differential diagnosis of neonatal early indirect hyperbilirubinemia because neonatal screening results may be delayed or missed completely.

Citing Articles

Unusual Presentation of Classical Galactosemia: A Case Report of Iranian Experience.

Alaee M, Saneifard H, Shakiba M, Hanifeh M, Moarefian S Clin Case Rep. 2025; 13(2):e70170.

PMID: 39973892 PMC: 11835960. DOI: 10.1002/ccr3.70170.


Pathogenic Novel Heterozygous Variant c.1076c>T p. (Ser359Phe) chr1: 120512166 in NOTCH2 Gene, Type 2 Alagille Syndrome Causing Neonatal Cholestasis: A Case Report.

Uddin M, Al Fulayyih S, Al Denaini F, Al Hatlani M Am J Case Rep. 2022; 23:e935840.

PMID: 36201396 PMC: 9552858. DOI: 10.12659/AJCR.935840.

References
1.
Ganjekarimi A, Senemar S, Tarami B, Bazrgar M . The prevalence and clinical study of galactosemia disease in a pilot screening program of neonates, southern iran. Iran J Public Health. 2012; 40(4):99-104. PMC: 3481732. View

2.
Woo H, Phornphutkul C, Laptook A . Early and severe indirect hyperbilirubinemia as a manifestation of galactosemia. J Perinatol. 2010; 30(4):295-7. DOI: 10.1038/jp.2009.136. View

3.
MILLIS S . Jaundice associated with galactosemia in the newborn. J Indiana State Med Assoc. 1958; 51(12):1656-7. View

4.
Ohlsson A, Guthenberg C, von Dobeln U . Galactosemia screening with low false-positive recall rate: the Swedish experience. JIMD Rep. 2013; 2:113-7. PMC: 3509849. DOI: 10.1007/8904_2011_59. View

5.
Pyhtila B, Shaw K, Neumann S, Fridovich-Keil J . Erratum to: Newborn Screening for Galactosemia in the United States: Looking Back, Looking Around, and Looking Ahead. JIMD Rep. 2014; 15:133. PMC: 4270863. DOI: 10.1007/8904_2014_369. View